Navigation Links
QRxPharma Announces Collaboration With Aesica
Date:7/22/2013

SYDNEY and BEDMINSTER, N.J., July 22, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a Collaboration Agreement with Aesica Formulation Development Limited, a subsidiary of Aesica Pharmaceuticals Limited, for the world-wide promotion of QRxPharma's proprietary Stealth Beadlets® abuse deterrence technology. Aesica supplies pharmaceutical contract development and manufacturing services globally and operates six manufacturing sites across the UK, Germany and Italy. Aesica offers controlled drug services across the supply chain for which abuse or diversion may occur and is actively building relationships for supplying controlled drug Active Pharmaceutical Ingredients (APIs) and finished dose products to market.

"We are delighted to announce our collaboration with Aesica," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "Their extensive experience in formulation development and contract manufacturing, together with their established client base in the controlled drug market, create a wonderful opportunity for our companies to collaborate in the application of our proprietary abuse deterrence technology by third party pharma companies."

Under the non-exclusive Collaboration Agreement, Aesica will promote QRxPharma's Stealth Beadlets technology for inclusion in their clients' existing formulations of controlled drugs.  Aesica will enter into fee-for-service contracts with such third parties for the development of the new Abuse Deterrent Formulations (ADF) of specific drugs of interest, whilst QRxPharma will negotiate license terms directly with each party.

QRxPharma's proprietary Stealth Beadlets abuse deterrence technology was developed for the MoxDuo CR (controlled release) formulation for the treatment of c
'/>"/>

SOURCE QRxPharma Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. QRxPharma Granted Additional US Patent on MoxDuo®
2. QRxPharma Granted US Patent On Hybrid Opioids
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Inivata, a Cambridge, England ... presence at the 2015 American Association for Cancer Research (AACR) ... Nitzan Rosenfeld and a poster presentation. Michael Stocum ... - 22 nd . The presentation, entitled ... forms part of a session on Recent Advances ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) ... - Global Strategic Business Report" report to their ... for ADME-Toxicology Testing in US$ Million by the following ... The report provides separate comprehensive analytics for ... Japan , Europe , ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) ... - Global Strategic Business Report" report to their ... for Mammography Equipment in US$ Thousands by the following ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... THE WOODLANDS, Texas, Feb. 16, 2012   Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... financial results on Wednesday, February 22, 2012 before the ... call and webcast to discuss clinical development progress and ...
... 16, 2012  2WIN! Global,s Bob Riefstahl will deliver the ... Diagnostic Sales Training and Development Conference in Phoenix next ... hearing it again and again from your sales and ... 2WIN! Global CEO and Founder, Bob Riefstahl. "For over ...
Cached Medicine Technology:Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012 22WIN! ® Global Keynotes at Upcoming Medical Device Conference: 2
(Date:4/17/2015)... (PRWEB) April 17, 2015 Scientists ... a multicenter team of U.S. and Venezuelan researchers, ... yet in humans among an isolated tribe of ... Venezuela. Bacterial diversity in the Yanomami, previously unexposed ... be nearly double that of people living in ...
(Date:4/17/2015)... Calvary Hospital recently announced Timothy P. Barr will be ... May 11. The Fund directs all fundraising efforts in support ... J. Spinelli, who retired several months ago. , “We are ... the important work that the Fund does every year,” said ... expand and bring our signature care to people who need ...
(Date:4/17/2015)... NJ (PRWEB) April 17, 2015 ... in the posterior pituitary and thought to help mothers ... between couples. To further substantiate this, new studies performed, ... the journal, Nature, and reported by Medical News Today ... a powerful influence over maternal social behavior. The study ...
(Date:4/17/2015)... New York, NY (PRWEB) April 17, 2015 ... is formulated to polish and perfect facial ... Ecuadorian Ivory Palm seeds and blend of energizing ... dulling dead skin cells that cause breakouts and ... , Star Ingredients: , Ecuadorian Ivory Palm Seeds, ...
(Date:4/17/2015)... 17, 2015 According to the ... 50 million Americans suffer from all types of allergies, ... eye allergies. Thanks to comprehensive allergy testing that’s being ... ), there’s now a way to get recommended treatment ... “Allergy triggers, or allergens, can vary by region of ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mario Badescu Skin Care Launches Botanical Exfoliating Scrub 2Health News:CareMed Urgent & Primary Care Now Offering Comprehensive Allergy Testing 2Health News:CareMed Urgent & Primary Care Now Offering Comprehensive Allergy Testing 3
... New England Journal of Medicine suggested that moderate drinking ... individuals. The study was conducted over a 12-year period ... osteopathic physicians and podiatrists, aged 40 to 75 years. ... frequency of drinking. ,The study showed that it ...
... A study which appeared in the clinical journal ... associated with a five-year risk of ocular hypertension, ... prevalence// of glaucoma, in Caucasians. The study was ... to 84, who received baseline assessments of refractive ...
... Cancer and Leukemia Group B (CALGB) and presented at ... the effectiveness of reducing the interval between successive doses ... rates in breast cancer// women. This study was conducted ... in the 1980s that suggested the value of increased ...
... cancer has been associated to many risk factors like ... consumption. Several earlier studies have linked alcohol to breast ... because smoking often accompanies drinking, researchers have not been ... ,Now, researchers from Cancer Research, UK, who included dozens ...
... American Medical Association published a recent comparative study done ... results from a telephone survey of people living in ... who were asked to name up to three stroke ... a similar survey conducted in 1995 to study the ...
... a recent study have found that people who take ... higher risk of developing gastrointestinal bleeding. The study which ... anti-depressant// users, who were compared for hospitalizations due to ... ,Researchers found people on selective serotonin reuptake inhibitors, or ...
Cached Medicine News:Health News:Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy" 2
The Unistik 3 family of single use safety lancets has 4 models for use across all clinical environments....
The Stat-Let lines of disposable lancets are all designed with the goals of providing a safe and easy to achieve capillary blood sampling. All of our lancets can be used by most current models of lan...
The BD Ultra-Fine 33 Lancets are the thinnest lancets available, which means that you'll experience less pain when taking a blood sample....
... flow and minimize pain when performing ... BD Microtainer Quikheel Lancet. The simple ... providing a precise and consistent incision, ... its casing, helping to protect you ...
Medicine Products: